Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1993 Oct;101(Suppl 3):257–261. doi: 10.1289/ehp.93101s3257

Genetic effects of dioxins in the spot test with mice.

R Fahrig 1
PMCID: PMC1521139  PMID: 8143627

Abstract

More than any other environmental chemicals, dioxins have been in the limelight of public interest for about 10 years. In addition to carcinogenicity, genetic risk is a cause for concern. Mutagenicity tests performed so far do not give a clear picture. The mutagenic potential of dioxins has to be considered weak or absent. Therefore, it seemed profitable to investigate comutagenicity and co-recombinogenicity of dioxins more thoroughly. The only useful method for investigating comutagenicity and co-recombinogenicity of dioxins in vivo is the spot test with mice. In this test system, a number of cocarcinogens and tumor promoters have shown comutagenic or co-recombinogenic effects. In the present study, tetrachlorodibenzo-p-dioxin (TCDD) and two environmental dioxin mixtures [pentachlorodibenzodioxin (PCDD) 1 and 2] were tested for genetic activity. Given alone, no mutagenic or recombinogenic effects could be observed. In combination with the carcinogenic mutagen ethyl nitrosourea (ENU) at concentrations of 128 micrograms/kg for PCCD 2, 314 micrograms/kg for PCDD 1, and 3 micrograms/kg for TCDD, a doubling of the genetic effectiveness of ENU was observed. The genetic risk can roughly be considered as 1:0.02 for TCDD:PCDD 2 and 1:0.01 for TCDD:PCDD 1. While PCDD 1 and 2 seem to enhance the mutagenic as well as the recombinogenic potential of ENU, TCDD showed mainly co-recombinogenic and antimutagenic activity. This characteristic indicates that TCDD is mainly a tumor promoter.

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fahrig R. A mammalian spot test: induction of genetic alterations in pigment cells of mouse embryos with x-rays and chemical mutagens. Mol Gen Genet. 1975 Jul 10;138(4):309–314. doi: 10.1007/BF00264800. [DOI] [PubMed] [Google Scholar]
  2. Fahrig R. Effects of bile acids on the mutagenicity and recombinogenicity of triethylene melamine in yeast strains MP1 and D61.M. Arch Toxicol. 1987;60(1-3):192–197. doi: 10.1007/BF00296979. [DOI] [PubMed] [Google Scholar]
  3. Fahrig R. Enhancement of carcinogen-induced mutations or recombinations by 12-O-tetradecanoyl-phorbol-13-acetate in the mammalian spot test. J Cancer Res Clin Oncol. 1987;113(1):61–66. doi: 10.1007/BF00389968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fahrig R. Evidence that induction and suppression of mutations and recombinations by chemical mutagens in S. cerevisiae during mitosis are jointly correlated. Mol Gen Genet. 1979 Jan 10;168(2):125–139. doi: 10.1007/BF00431439. [DOI] [PubMed] [Google Scholar]
  5. Fahrig R. Genetic mode of action of cocarcinogens and tumor promoters in yeast and mice. Mol Gen Genet. 1984;194(1-2):7–14. doi: 10.1007/BF00383490. [DOI] [PubMed] [Google Scholar]
  6. Fahrig R., Neuhäuser-Klaus A. Similar pigmentation characteristics in the specific-locus and the mammalian spot test. A way to distinguish between induced mutation and recombination. J Hered. 1985 Nov-Dec;76(6):421–426. doi: 10.1093/oxfordjournals.jhered.a110137. [DOI] [PubMed] [Google Scholar]
  7. Fahrig R. Tests for recombinagens in mammals in vivo. Mutat Res. 1992 Dec 1;284(1):177–183. doi: 10.1016/0027-5107(92)90031-v. [DOI] [PubMed] [Google Scholar]
  8. Fahrig R. The effect of dose and time on the induction of genetic alterations in Saccharomyces cerevisiae by aminoacridines in the presence and absence of visible light irradiation in comparison with the dose-effect-curves of mutagens with other type of action. Mol Gen Genet. 1976 Mar 22;144(2):131–140. doi: 10.1007/BF02428101. [DOI] [PubMed] [Google Scholar]
  9. Geiger L. E., Neal R. A. Mutagenicity testing of 2,3,7,8-tetrachlordibenzo-p-dioxin in histidine auxotrophs of Salmonella typhimurium. Toxicol Appl Pharmacol. 1981 Jun 15;59(1):125–129. doi: 10.1016/0041-008x(81)90459-2. [DOI] [PubMed] [Google Scholar]
  10. Giri A. K. Mutagenic and genotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin, a review. Mutat Res. 1986 Nov;168(3):241–248. doi: 10.1016/0165-1110(86)90022-9. [DOI] [PubMed] [Google Scholar]
  11. Jackson W. T. Regulation of mitosis. 3. Cytological effects of 2,4,5-trichloro-phenoxyacetic acid and of dioxin contaminants in 2,4,5-T formulations. J Cell Sci. 1972 Jan;10(1):15–25. doi: 10.1242/jcs.10.1.15. [DOI] [PubMed] [Google Scholar]
  12. Kociba R. J., Keyes D. G., Beyer J. E., Carreon R. M., Wade C. E., Dittenber D. A., Kalnins R. P., Frauson L. E., Park C. N., Barnard S. D. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 1978 Nov;46(2):279–303. doi: 10.1016/0041-008x(78)90075-3. [DOI] [PubMed] [Google Scholar]
  13. Kouri R. E., Rude T. H., Joglekar R., Dansette P. M., Jerina D. M., Atlas S. A., Owens I. S., Nebert D. W. 2,3,7,8-tetrachlorodibenzo-p-dioxin as cocarcinogen causing 3-methylcholanthrene-initiated subcutaneous tumors in mice genetically "nonresponsive" at Ah locus. Cancer Res. 1978 Sep;38(9):2777–2783. [PubMed] [Google Scholar]
  14. Liskay R. M., Stachelek J. L. Evidence for intrachromosomal gene conversion in cultured mouse cells. Cell. 1983 Nov;35(1):157–165. doi: 10.1016/0092-8674(83)90218-0. [DOI] [PubMed] [Google Scholar]
  15. Meyne J., Allison D. C., Bose K., Jordan S. W., Ridolpho P. F., Smith J. Hepatotoxic doses of dioxin do not damage mouse bone marrow chromosomes. Mutat Res. 1985 Jul;157(1):63–69. doi: 10.1016/0165-1218(85)90050-3. [DOI] [PubMed] [Google Scholar]
  16. Mortelmans K., Haworth S., Speck W., Zeiger E. Mutagenicity testing of agent orange components and related chemicals. Toxicol Appl Pharmacol. 1984 Aug;75(1):137–146. doi: 10.1016/0041-008x(84)90084-x. [DOI] [PubMed] [Google Scholar]
  17. Pitot H. C., Goldsworthy T., Campbell H. A., Poland A. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine. Cancer Res. 1980 Oct;40(10):3616–3620. [PubMed] [Google Scholar]
  18. Poland A., Palen D., Glover E. Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature. 1982 Nov 18;300(5889):271–273. doi: 10.1038/300271a0. [DOI] [PubMed] [Google Scholar]
  19. Rogers A. M., Andersen M. E., Back K. C. Mutagenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin and perfluoro-n-decanoic acid in L5178Y mouse-lymphoma cells. Mutat Res. 1982 Dec;105(6):445–449. doi: 10.1016/0165-7992(82)90192-0. [DOI] [PubMed] [Google Scholar]
  20. Wassom J. S., Huff J. E., Loprieno N. A review of the genetic toxicology of chlorinated dibenzo-p-dioxins. Mutat Res. 1977;47(3-4):141–160. doi: 10.1016/0165-1110(77)90001-x. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of American Chemical Society

RESOURCES